Rating Change
Needham analysts initiated coverage on LB Pharmaceuticals Inc Common Stock (NASDAQ:LBRX) with a rating of Buy on October 02, 2026.
new coverageNASDAQ:LBRX
Needham Initiates Coverage on LB Pharmaceuticals Inc Common Stock (LBRX) with Buy
Needham analysts initiated coverage on LB Pharmaceuticals Inc Common Stock (NASDAQ:LBRX) with a rating of Buy on October 02, 2026.
At publication ·
What changed
LB Pharmaceuticals Inc Common Stock (NASDAQ:LBRX) · new coverage
- Firm
- Needham
- Rating
- Buy
- Price at event
- $35.15
- Market capitalization
- $508.8M
At a glance
Key takeaways
- Needham initiated Buy coverage on LB Pharmaceuticals (LBRX) on October 2, 2026, with the stock trading at $35.15 and a market capitalization of $508.8 million.
Market Context
LB Pharmaceuticals Inc Common Stock operates in the Healthcare sector. The stock currently trades at $35.15 with a market capitalization of $508.8M.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for LB Pharmaceuticals Inc Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for LB Pharmaceuticals Inc Common Stock
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 02, 2026 | Needham | Buy | N/A |
| Aug 24, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 12, 2026 | BMO Capital | Outperform | N/A |
| Aug 03, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 21, 2026 | BMO Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View LBRX Stock Page
Frequently Asked Questions
What does the Buy rating mean for LBRX?
A rating of Buy from Needham reflects the analyst's outlook on LB Pharmaceuticals Inc Common Stock (NASDAQ:LBRX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the LBRX forecast page.